The ViiV’s Study Indicates the Importance of Choosing Suitable Drugs Announcement ViiV Healthcare, the expert specialist HIV company majorly owned by GSK, along with Shionogi and Pfizer as shareholders, introduced data from its phase 3b volition study, which elaborates that around 89% (n...
Zimmer Biomet to Acquire Monogram Technologies Announcement Zimmer Biomet Holdings, Inc. a popular medical technology and Monogram Technologies, a known orthopedic robotics company, have signed an agreement to acquire outstanding shares of stock of monogram to receive an upfront payment of $4....
Acadia’s R&D Day and Upgradation New Products and Strong R&D Acadia Pharmaceuticals, in its 32 years of business and has currently organized its first R&D day, predicting annual sales of around $12 billion from its investigational chain. Daybue for Rett syndrome and Nuplazid ...
CEL-SCI’s Agreement Approach to a Saudi Arabian Pharma Company Announcement The CEL-SCI corporation (NYSE American CVM) has approached an agreement with a known Saudi Arabian premier healthcare and pharmaceutical company for a strategic partnership that includes commercial and regulatory a...
Nutcracker and Elegen’s Pilot Program Announcement The nutcracker therapeutics a RNA design and manufacturer and Elegen, a DNA manufacturer are introducing a pilot program to describe the company’s first ever full synthetic, cell-free manufacturing platform for RNA-powered personaliz...
‘Weight loss medication’ a New Trend in the Healthcare Market Announcement At the American Diabetes Association’s annual meeting, the need for new weight-loss medicines, primarily for muscle preservation and showing fewer side effects, was the center of concern. The topic enter...
Adopting Precision Diagnostics to Shape the Future of Oncology Therapies A Step Towards the Future of Advanced Therapies The AI-based analysis and digital imaging are believed to be advanced precision oncology therapies for the next generation to achieve potential and access to all patients. The...
Pfizer and Astellas' Positive Results Mark a Significant Improvement Image Credits: The Astellas US Newsroom Announcement Pfizer Inc. and Astellas Pharma Inc. proved their potential with the positive results directly from the overall survival (OS) analysis from its phase 3 study of EMBARK. A st...
Max Healthcare is Set to Flourish in the Healthcare Industry Image Credits: The Financial Express Efforts The hospital chain is expanding and focusing on growth in the Delhi-NCR region. The region is experiencing excellent growth in margins and ARPOB, and occupancy, which reflects the early day...
Novartis and Pan-Canadian’s Partnership has Finalized Negotiations Announcement Novartis Pharmaceuticals Canada Inc. finally confirms its partnership with Pan-Canadian Pharmaceutical by settling down with an effective negotiation on (Pcpa) public reimbursement of Cosentyx (secukinumab) for...
